» Articles » PMID: 30658725

Effect of Ethanol on Lipid Metabolism

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2019 Jan 20
PMID 30658725
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatic lipid metabolism is a series of complex processes that control influx and efflux of not only hepatic lipid pools, but also organismal pools. Lipid homeostasis is usually tightly controlled by expression, substrate supply, oxidation and secretion that keep hepatic lipid pools relatively constant. However, perturbations of any of these processes can lead to lipid accumulation in the liver. Although it is thought that these responses are hepatic arms of the 'thrifty genome', they are maladaptive in the context of chronic fatty liver diseases. Ethanol is likely unique among toxins, in that it perturbs almost all aspects of hepatic lipid metabolism. This complex response is due in part to the large metabolic demand placed on the organ by alcohol metabolism, but also appears to involve more nuanced changes in expression and substrate supply. The net effect is that steatosis is a rapid response to alcohol abuse. Although transient steatosis is largely an inert pathology, the chronicity of alcohol-related liver disease seems to require steatosis. Better and more specific understanding of the mechanisms by which alcohol causes steatosis may therefore translate into targeted therapies to treat alcohol-related liver disease and/or prevent its progression.

Citing Articles

Impact of Alcohol Intake on Skeletal Muscle: A Large Cross-Sectional Analysis in Japanese Adults.

Matsui M, Fukuda A, Onishi S, Ushiro K, Nishikawa T, Asai A Nutrients. 2025; 17(5).

PMID: 40077764 PMC: 11901683. DOI: 10.3390/nu17050894.


Metabolic outcomes in non-alcoholic and alcoholic steatotic liver disease among Korean and American adults.

Kim Y, Lee T, Oh C BMC Gastroenterol. 2025; 25(1):110.

PMID: 39994673 PMC: 11853905. DOI: 10.1186/s12876-025-03687-4.


Circadian rhythms and inflammatory diseases of the liver and gut.

Ferrell J Liver Res. 2025; 7(3):196-206.

PMID: 39958387 PMC: 11791922. DOI: 10.1016/j.livres.2023.08.004.


Changes in drinking levels and metabolic dysfunction-associated steatotic liver disease: a longitudinal study from the China multi-ethnic cohort study.

Zhang N, Li J, Xie X, Hu Y, Chen H, Zhang Y BMC Public Health. 2025; 25(1):556.

PMID: 39934719 PMC: 11817541. DOI: 10.1186/s12889-025-21752-1.


MetALD: Clinical aspects, pathophysiology and treatment.

Gratacos-Gines J, Arino S, Sancho-Bru P, Bataller R, Pose E JHEP Rep. 2025; 7(2):101250.

PMID: 39897615 PMC: 11782861. DOI: 10.1016/j.jhepr.2024.101250.


References
1.
Ferre P, Foufelle F . Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab. 2010; 12 Suppl 2:83-92. DOI: 10.1111/j.1463-1326.2010.01275.x. View

2.
Park S, Gammon S, Knippers J, Paulsen S, Rubink D, Winder W . Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J Appl Physiol (1985). 2002; 92(6):2475-82. DOI: 10.1152/japplphysiol.00071.2002. View

3.
Esfandiari F, You M, Villanueva J, Wong D, French S, Halsted C . S-adenosylmethionine attenuates hepatic lipid synthesis in micropigs fed ethanol with a folate-deficient diet. Alcohol Clin Exp Res. 2007; 31(7):1231-9. DOI: 10.1111/j.1530-0277.2007.00407.x. View

4.
He J, Lee J, Febbraio M, Xie W . The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease. Exp Biol Med (Maywood). 2011; 236(10):1116-21. DOI: 10.1258/ebm.2011.011128. View

5.
Ontko J . Effects of ethanol on the metabolism of free fatty acids in isolated liver cells. J Lipid Res. 1973; 14(1):78-86. View